Clinical Trial Update: Interleukin-2 for Refractory Chronic Spontaneous Urticaria [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates a Phase 2/3 study of interleukin-2 for refractory chronic spontaneous urticaria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Chronic Spontaneous Uriticaria | Phase 2, Phase 3 | Status: RECRUITING